SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001214659-17-003555
Filing Date
2017-05-22
Accepted
2017-05-22 20:45:12
Documents
1
Period of Report
2017-05-20

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-38869.html 4  
1 PRIMARY DOCUMENT marketforms-38869.xml 4 4421
  Complete submission text file 0001214659-17-003555.txt   5792
Mailing Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545
Business Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545 (510) 856-5600
Anthera Pharmaceuticals Inc (Issuer) CIK: 0001316175 (see all company filings)

IRS No.: 201852016 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 5000 SHORELINE COURT, SUITE 101 SOUTH SAN FRANCISCO CA 94080
Business Address
Dickinson Klara (Reporting) CIK: 0001339895 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34637 | Film No.: 17862491